The resolution recognizes Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, as a fatal condition that leads to the progressive degeneration of motor neurons, resulting in loss of muscle control and eventual quadriplegia. It highlights the alarming statistics surrounding ALS, including the frequency of new diagnoses and deaths, the average survival time post-diagnosis, and the lack of known causes, prevention methods, or cures. The resolution also emphasizes the increased risk of ALS among military veterans and the financial burden it places on patients and their families.

In light of these challenges, the resolution underscores the importance of access to new therapies, medical equipment, and communication technologies for those affected by ALS. It acknowledges the critical role of clinical trials in advancing treatment options and improving quality of life. The resolution also recognizes the ALS Association's significant contributions to ALS research and its commitment to finding a cure. To raise awareness and support for those living with ALS, the resolution declares May 2026 as ALS Awareness Month in Alabama, encouraging residents to observe and promote this initiative.